Oral nonabsorbable antibiotics for prevention of recurrent cholangitis; a brief report study
Infection · 2025
DOI: 10.1007/s15010-025-02491-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection, 2025. Verfasst von Jesús Fortún und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Hospital Universitario "Ramon y Cajal", Avda Colmenar Km 9,1, Madrid, 28034, Spain. fortunabete@gmail.com. Hauptthemen laut MEDLINE: Cholangitis, Secondary Prevention, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Alcalá.
Abstract (Originalsprache)
Background
Patients with recurrent cholangitis are at risk of developing life-threatening sepsis. Selective decontamination of the digestive tract (SDD) involving oral nonabsorbable antibiotics has been primarily applied to children undergoing Kasai portoenterostomy surgery.
Methods
In this study, SDD containing colistin, tobramycin, and nystatin was administered to eight patients with recurrent cholangitis, and the incidence density before and after SDD administration was analyzed.
Results
The overall incidence density of cholangitis requiring hospital admission was 0.37 per 100 patient days during the SDD period and was significantly lower than observed before SDD administration (1.05 per 100 patient days) [RR: 0.35 (95% CI: 0.21–0.59); p:
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Hospital Universitario "Ramon y Cajal", Avda Colmenar Km 9,1, Madrid, 28034, Spain. fortunabete@gmail.com.
- Instituto de Investigación Sanitaria Hospital "Ramón y Cajal" (IRYCIS), Madrid, 28034, Spain. fortunabete@gmail.com.
- Department of Medicine, Universidad Alcalá, Madrid, 28801, Spain. fortunabete@gmail.com.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de 5 Salud Carlos III, Madrid, 28029, Spain. fortunabete@gmail.com.
- Instituto de Investigación Sanitaria Hospital "Ramón y Cajal" (IRYCIS), Madrid, 28034, Spain.
- Department of Medicine, Universidad Alcalá, Madrid, 28801, Spain.
Förderung
- Universidad de Alcalá
Zitieren
APA
Fortún, J., Rodríguez-Gandía, M. A., Pintado, V., Martín-Dávila, P., García-González, M., Graus, J., Martín-Mateos, R., Saez de la Fuente, J., Muriel, A., & Moreno, S. (2025). Oral nonabsorbable antibiotics for prevention of recurrent cholangitis; a brief report study. Infection. https://doi.org/10.1007/s15010-025-02491-2
Vancouver
Fortún J, Rodríguez-Gandía MA, Pintado V, Martín-Dávila P, García-González M, Graus J, et al. Oral nonabsorbable antibiotics for prevention of recurrent cholangitis; a brief report study. Infection. 2025. doi:10.1007/s15010-025-02491-2
BibTeX
@article{Fortn2025,
author = {Fortún, Jesús and Rodríguez-Gandía, Miguel Angel and Pintado, Vicente and Martín-Dávila, Pilar and García-González, Miguel and Graus, Javier and Martín-Mateos, Rosa and Saez de la Fuente, Javier and Muriel, Alfonso and Moreno, Santiago},
title = {Oral nonabsorbable antibiotics for prevention of recurrent cholangitis; a brief report study},
journal = {Infection},
year = {2025},
doi = {10.1007/s15010-025-02491-2}
}
EUVIMED